![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 49, 47870-47877, December 6, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Genetic Pharmacology Unit, Experimental Therapeutics
Branch, NINDS, National Institutes of Health,
Bethesda, Maryland 20892-1406
Parkinson's disease (PD) is characterized by
loss of dopaminergic neurons in the substantia nigra and by the
presence of ubiquitinated cytoplasmic inclusions known as Lewy bodies.
Parkin Accumulation in Aggresomes Due to
Proteasome Impairment*
-Synuclein and Parkin are two of the proteins associated with
inherited forms of PD and are found in Lewy bodies. Whereas numerous
reports indicate the tendency of
-synuclein to aggregate both
in vitro and in vivo, no information is
available about similar physical properties for Parkin. Here we show
that overexpression of Parkin in the presence of proteasome inhibitors
leads to the formation of aggresome-like perinuclear inclusions. These
eosinophilic inclusions share many characteristics with Lewy bodies,
including a core and halo organization, immunoreactivity to ubiquitin,
-synuclein, synphilin-1, Parkin, molecular chaperones, and
proteasome subunit as well as staining of some with thioflavin S. We
propose that the process of Lewy body formation may be akin to that of
aggresome-like structures. The tendency of wild-type Parkin to
aggregate and form inclusions may have implications for the
pathogenesis of sporadic PD.
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: NINDS, National
Institutes of Health, 10 Center Dr., MSC 1406, Bethesda, MD 20892-1406. Tel.: 301-496-7872; Fax: 301-496-6609; E-mail: MouradianM@
ninds.nih.gov.
This article has been cited by other articles:
![]() |
K. Kawahara, M. Hashimoto, P. Bar-On, G. J. Ho, L. Crews, H. Mizuno, E. Rockenstein, S. Z. Imam, and E. Masliah {alpha}-Synuclein Aggregates Interfere with Parkin Solubility and Distribution: ROLE IN THE PATHOGENESIS OF PARKINSON DISEASE J. Biol. Chem., March 14, 2008; 283(11): 6979 - 6987. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Rott, R. Szargel, J. Haskin, V. Shani, A. Shainskaya, I. Manov, E. Liani, E. Avraham, and S. Engelender Monoubiquitylation of {alpha}-Synuclein by Seven in Absentia Homolog (SIAH) Promotes Its Aggregation in Dopaminergic Cells J. Biol. Chem., February 8, 2008; 283(6): 3316 - 3328. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Olzmann, L. Li, M. V. Chudaev, J. Chen, F. A. Perez, R. D. Palmiter, and L.-S. Chin Parkin-mediated K63-linked polyubiquitination targets misfolded DJ-1 to aggresomes via binding to HDAC6 J. Cell Biol., September 7, 2007; 178(6): 1025 - 1038. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. P. Marx, A. S. Soehn, D. Berg, C. Melle, C. Schiesling, M. Lang, S. Kautzmann, K. M. Strauss, T. Franck, S. Engelender, et al. The proteasomal subunit S6 ATPase is a novel synphilin-1 interacting protein--implications for Parkinson's disease FASEB J, June 1, 2007; 21(8): 1759 - 1767. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Avraham, R. Rott, E. Liani, R. Szargel, and S. Engelender Phosphorylation of Parkin by the Cyclin-dependent Kinase 5 at the Linker Region Modulates Its Ubiquitin-Ligase Activity and Aggregation J. Biol. Chem., April 27, 2007; 282(17): 12842 - 12850. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Maloyan, J. Gulick, C. G. Glabe, R. Kayed, and J. Robbins Exercise reverses preamyloid oligomer and prolongs survival in {alpha}B-crystallin-based desmin-related cardiomyopathy PNAS, April 3, 2007; 104(14): 5995 - 6000. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mittal, D. Dubey, K. Yamakawa, and S. Ganesh Lafora disease proteins malin and laforin are recruited to aggresomes in response to proteasomal impairment Hum. Mol. Genet., April 1, 2007; 16(7): 753 - 762. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Hampe, H. Ardila-Osorio, M. Fournier, A. Brice, and O. Corti Biochemical analysis of Parkinson's disease-causing variants of Parkin, an E3 ubiquitin-protein ligase with monoubiquitylation capacity Hum. Mol. Genet., July 1, 2006; 15(13): 2059 - 2075. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Apaja, J. T. Tuusa, E. M. Pietila, H. J. Rajaniemi, and U. E. Petaja-Repo Luteinizing Hormone Receptor Ectodomain Splice Variant Misroutes the Full-Length Receptor into a Subcompartment of the Endoplasmic Reticulum Mol. Biol. Cell, May 1, 2006; 17(5): 2243 - 2255. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. W. Smith, Z. Pei, H. Jiang, D. J. Moore, Y. Liang, A. B. West, V. L. Dawson, T. M. Dawson, and C. A. Ross Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin, and mutant LRRK2 induces neuronal degeneration PNAS, December 20, 2005; 102(51): 18676 - 18681. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hideshima, J. E. Bradner, D. Chauhan, and K. C. Anderson Intracellular Protein Degradation and Its Therapeutic Implications Clin. Cancer Res., December 15, 2005; 11(24): 8530 - 8533. [Full Text] [PDF] |
||||
![]() |
S. R. Sriram, X. Li, H. S. Ko, K. K.K. Chung, E. Wong, K. L. Lim, V. L. Dawson, and T. M. Dawson Familial-associated mutations differentially disrupt the solubility, localization, binding and ubiquitination properties of parkin Hum. Mol. Genet., September 1, 2005; 14(17): 2571 - 2586. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Fratta, W. K. Engel, J. McFerrin, K. J.A. Davies, S. W. Lin, and V. Askanas Proteasome Inhibition and Aggresome Formation in Sporadic Inclusion-Body Myositis and in Amyloid-{beta} Precursor Protein-Overexpressing Cultured Human Muscle Fibers Am. J. Pathol., August 1, 2005; 167(2): 517 - 526. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Haraguchi, T. Mabuchi, S. Hirata, T. Shoda, K. Hoshi, K. Akasaki, and S. Yokota Chromatoid Bodies: Aggresome-like Characteristics and Degradation Sites for Organelles of Spermiogenic Cells J. Histochem. Cytochem., April 1, 2005; 53(4): 455 - 465. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Jiang, Q. Jiang, and J. Feng Parkin Increases Dopamine Uptake by Enhancing the Cell Surface Expression of Dopamine Transporter J. Biol. Chem., December 24, 2004; 279(52): 54380 - 54386. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Lehotzky, L. Tirian, N. Tokesi, P. Lenart, B. Szabo, J. Kovacs, and J. Ovadi Dynamic targeting of microtubules by TPPP/p25 affects cell survival J. Cell Sci., December 1, 2004; 117(25): 6249 - 6259. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tanaka, Y. M. Kim, G. Lee, E. Junn, T. Iwatsubo, and M. M. Mouradian Aggresomes Formed by {alpha}-Synuclein and Synphilin-1 Are Cytoprotective J. Biol. Chem., February 6, 2004; 279(6): 4625 - 4631. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M.K. Muqit, S. M. Davidson, M. D. Payne Smith, L. P. MacCormac, S. Kahns, P. H. Jensen, N. W. Wood, and D. S. Latchman Parkin is recruited into aggresomes in a stress-specific manner: over-expression of parkin reduces aggresome formation but can be dissociated from parkin's effect on neuronal survival Hum. Mol. Genet., January 1, 2004; 13(1): 117 - 135. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Imai, M. Soda, T. Murakami, M. Shoji, K. Abe, and R. Takahashi A Product of the Human Gene Adjacent to parkin Is a Component of Lewy Bodies and Suppresses Pael Receptor-induced Cell Death J. Biol. Chem., December 19, 2003; 278(51): 51901 - 51910. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Fortun, W. A. Dunn Jr, S. Joy, J. Li, and L. Notterpek Emerging Role for Autophagy in the Removal of Aggresomes in Schwann Cells J. Neurosci., November 19, 2003; 23(33): 10672 - 10680. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Cookson, P. J. Lockhart, C. McLendon, C. O'Farrell, M. Schlossmacher, and M. J. Farrer RING finger 1 mutations in Parkin produce altered localization of the protein Hum. Mol. Genet., November 15, 2003; 12(22): 2957 - 2965. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. C. Ardley, G. B. Scott, S. A. Rose, N. G. S. Tan, A. F. Markham, and P. A. Robinson Inhibition of Proteasomal Activity Causes Inclusion Formation in Neuronal and Non-Neuronal Cells Overexpressing Parkin Mol. Biol. Cell, November 1, 2003; 14(11): 4541 - 4556. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Junn, R. D. Ronchetti, M. M. Quezado, S.-Y. Kim, and M. M. Mouradian Tissue transglutaminase-induced aggregation of alpha -synuclein: Implications for Lewy body formation in Parkinson's disease and dementia with Lewy bodies PNAS, February 18, 2003; 100(4): 2047 - 2052. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |